IP Library Granted Patent US 9,650,624
Granted Patent B2
US 9,650,624 · App. 14/142,398 · Granted May 16, 2017

DHAD variants for butanol production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,650,624
App. No.
14/142,398
Granted
May 16, 2017
Kind
B2
Abstract

Dihydroxy-acid dehydratase (DHAD) variants that display increased DHAD activity are disclosed. Such enzymes can result in increased production of compounds from DHAD requiring biosynthetic pathways. Also disclosed are isolated nucleic acids encoding the DHAD variants, recombinant host cells comprising the isolated nucleic acid molecules, and methods of producing butanol.

Claims (13)

1. An isolated polypeptide or fragment thereof having dihydroxy-acid dehydratase (DHAD) activity, wherein the polypeptide or fragment thereof comprises an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO: 565, and wherein the amino acid sequence comprises a deletion of about 5 to about 20 amino acids from the C-terminal end of the amino acid sequence.

2. The isolated polypeptide or fragment thereof of claim 1 , wherein the amino acid sequence further comprises one or more amino acid substitutions selected from P378A, P378G, P378V, P378I, P378L, G383S, G383A, G383V, G383L, G383I, I387V, I387M, I387L, I387G, I387A, L388I, L388V, L388A, and L388M.

3. The isolated polypeptide or fragment thereof of claim 1 , wherein the polypeptide or fragment thereof having DHAD activity catalyzes the conversion of 2,3-dihydroxyisovalerate to α-ketoisovalerate.

4. The isolated polypeptide or fragment thereof of claim 1 , further comprising a polycysteine or polyhistidine tag.

5. The isolated polypeptide or fragment thereof of claim 4 , further comprising the amino acid sequence of SEQ ID NO:589.

6. The isolated polypeptide or fragment thereof of claim 2 , wherein the amino acid motif comprises the amino acid sequence of SEQ ID NO:573.

7. The isolated polypeptide or fragment thereof of claim 1 , wherein the polypeptide or fragment thereof having DHAD activity is a [2Fe-2S] 2+ DHAD.

8. The isolated polypeptide or fragment thereof of claim 1 , wherein the polypeptide or fragment thereof having DHAD activity has an amino acid sequence that matches the Profile Hidden Markov Model (HMM) of Table 6 with an E value of <10 5 .

9. The isolated polypeptide or fragment thereof of claim 1 , wherein the polypeptide or fragment thereof having DHAD activity comprises three conserved cysteines corresponding to positions 56, 129, and 201 in the amino acid sequences of the Streptococcus mutans DHAD corresponding to SEQ ID NO:544.

10. The isolated polypeptide or fragment thereof of claim 1 , wherein the polypeptide or fragment further comprises a polypeptide sequence selected from SEQ ID NO: 723, SEQ ID NO: 724, SEQ ID NO: 725, SEQ ID NO: 726, SEQ ID NO: 727, SEQ ID NO: 728, SEQ ID NO: 729, SEQ ID NO: 730, SEQ ID NO: 731, SEQ ID NO: 732, SEQ ID NO: 733, SEQ ID NO: 734, SEQ ID NO: 735, SEQ ID NO: 736, SEQ ID NO: 737, SEQ ID NO: 738, SEQ ID NO:

739, SEQ ID NO: 740, SEQ ID NO: 741, SEQ ID NO: 742, SEQ ID NO: 743, SEQ ID NO: 744, SEQ ID NO: 745, SEQ ID NO: 746, SEQ ID NO: 747, and SEQ ID NO: 748.

11. The isolated polypeptide or fragment thereof of claim 1 , wherein the amino acid sequence comprises a deletion of about 5 to about 15 amino acids from the C-terminal end of the amino acid sequence.

12. The isolated polypeptide or fragment thereof of claim 1 , wherein the amino acid sequence comprises a deletion of 9 C-terminal amino acids.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2016
From: ROTHMAN, STEVEN CARY; MAGGIO-HALL, LORI ANN; YE, RICK W; PAUL, BRIAN JAMES
To: BUTAMAX ADVANCED BIOFUELS LLC
Reel/Frame 038278/0424 →